Translational Haematology
Our Translational Hematology group was created with the aim of generating knowledge in the field of hematology and collaborating with other groups for the implementation of projects. Our activity is based on a broad portfolio of clinical trials, basic research projects and registry studies. The area of knowledge in which we focus is the study of the immune system and its relationship with oncohematological diseases and their infectious complications, cell therapy, study of the adverse effects of drugs and optimization in obtaining and using blood components in Transfusion Therapy.
Search for publications
Only original articles, editorials, guidelines.
-
Rosa-Rosa JM, Cuenca I, Medina A, Vázquez I, Sánchez-delaCruz A, Buenache N, Sánchez R, Jiménez C, Rosiñol L, Gutiérrez NC, Ruiz-Heredia Y, Barrio S, Oriol A, Martin-Ramos ML, Blanchard MJ, Ayala R, Ríos-Tamayo R, Sureda A, Hernández MT, de la Rubia J, Alkorta-Aranburu G, Agirre X, Bladé J, Mateos MV, Lahuerta JJ, San-Miguel JF, Calasanz MJ, Garcia-Sanz R, Martínez-Lopez J.
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
Cancers . 14(20): . Number of citations: 16
-
Tamariz-Amador LE, Rodríguez-Otero P, Jiménez-Ubieto A, Rosiñol L, Oriol A, Ríos R, Sureda A, Blanchard MJ, Hernández MT, Cabañas Perianes V, Jarque I, Bargay J, Gironella M, De Arriba F, Palomera L, Gonzalez-Montes Y, Martí JM, Krsnik I, Arguiñano JM, González ME, Casado LF, González-Rodriguez AP, López-Anglada L, Puig N, Cedena MT, Paiva B, Mateos MV, San-Miguel J, Lahuerta JJ, Bladé J, Trocóniz IF.
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia . 22(9): 844-852. Number of citations: 3
-
Battipaglia G, Labopin M, Blaise D, Diez-Martin JL, Bazarbachi A, Vitek A, Chevallier P, Castagna L, Grillo G, Daguindau E, López-Jiménez J, Koc Y, Ruggeri A, Nagler A, Mohty M.
Impact of the Addition of Antithymocyte Globulin to Post- Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Transplantation and Cellular Therapy . 28(9): . Number of citations: 33
-
Antic D, Milic N, Chatzikonstantinou T, Scarfò L, Otasevic V, Rajovic N, Allsup D, Alonso Cabrero A, Andres M, Baile Gonzales M, Capasso A, Collado R, Cordoba R, Cuéllar-García C, Correa JG, De Paoli L, De Paolis MR, Del Poeta G, Dimou M, Doubek M, Efstathopoulou M, El-Ashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Lopez-Garcia A, García-Marco JA, García-Serra R, Gentile M, Gimeno E, da Silva MG, Gutwein O, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Itchaki G, Jaksic O, Janssens A, Kalashnikova OB, Kalicinska E, Kater AP, Kersting S, Koren-Michowitz M, Labrador J, Lad D, Laurenti L, Fresa A, Levin MD, Mayor Bastida C, Malerba L, Marasca R, Marchetti M, Marquet J, Mihaljevic B, Milosevic I, Mirás F, Morawska M, Motta M, Munir T, Murru R, Nunes R, Olivieri J, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Reda G, Rigolin GM, Shrestha A, Šimkovic M, Smirnova S, Špacek M, Sportoletti P, Stanca O, Stavroyianni N, Te Raa D, Tomic K, Tonino S, Trentin L, Van Der Spek E, van Gelder M, Varettoni M, Visentin A, Vitale C, Vukovic V, Wasik-Szczepanek E, Wróbel T, Segundo LYS, Yassin M, Coscia M, Rambaldi A, Montserrat E, Foà R, Cuneo A, Carrier M, Ghia P, Stamatopoulos K.
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
Journal of Hematology & Oncology . 15(1): 116-116. Number of citations: 9
-
Castaño-Bonilla T, Barragán E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, García-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-López J, Martínez-López J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Castillo TB, Larrayoz MJ, Amigo R, Jiménez-Velasco A, Sánchez J, Ayala R, Blas C, Lainez D, Serrano-López J, Sanz MA, Alonso-Domínguez JM, Montesinos P.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group
DISEASE MARKERS . 2022: 3132941-3132941. Number of citations: 4
-
Vigón L, Galán M, Torres M, Martín-Galiano AJ, Rodríguez-Mora S, Mateos E, Corona M, Malo R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Martínez-Laso J, López-Huertas MR, Coiras M.
Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort.
PLoS One . 17(8): . Number of citations: 17
-
Sánchez R, Dorado S, Ruíz-Heredia Y, Martín-Muñoz A, Rosa-Rosa JM, Ribera J, García O, Jimenez-Ubieto A, Carreño-Tarragona G, Linares M, Rufián L, Juárez A, Carrillo J, Espino MJ, Cáceres M, Expósito S, Cuevas B, Vanegas R, Casado LF, Torrent A, Zamora L, Mercadal S, Coll R, Cervera M, Morgades M, Hernández-Rivas JÁ, Bravo P, Serí C, Anguita E, Barragán E, Sargas C, Ferrer-Marín F, Sánchez-Calero J, Sevilla J, Ruíz E, Villalón L, Del Mar Herráez M, Riaza R, Magro E, Steegman JL, Wang C, de Toledo P, García-Gutiérrez V, Ayala R, Ribera JM, Barrio S, Martínez-López J.
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Scientific Reports . 12(1): 13057-13057. Number of citations: 12
-
Lloret-Madrid P, Rodríguez-Veiga R, Bergua JM, Algarra JLA, Botella C, Rodríguez-Arbolí E, Bernal T, Tormo M, Calbacho M, Salamero O, Serrano J, Noriega V, López-López JA, Vives S, López-Lorenzo JL, Colorado M, Vidriales MB, Boyero RG, Olave MT, Herrera P, Arce O, Barrios M, Sayas MJ, Polo M, Gómez-Roncero MI, Barragán E, Ayala R, Chillón C, Calasanz MJ, Paiva B, Boluda B, Casas-Avilés I, Sánchez MJ, Rodríguez-Medina C, Cuevas L, Raposo-Puglia JÁ, Mateos MC, Olivares M, Martínez-Chamorro C, Alonso N, Suárez S, Sánchez-Vadillo I, Rodríguez MS, González BJ, Martínez-Francés A, Cuello R, Fernández A, Martínez-Cuadrón D, Labrador J, Montesinos P.
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.
HAEMATOLOGICA . : .
-
Gonzalez C, Guerrero C, Larrayoz M, Zabaleta A, Zhao J, Kostopoulos IV, Tsitsilonis O, Terpos E, Gutierrez NC, Fernandez M, Calasanz MJJ, Rodriguez-Otero P, Prosper F, Lozano T, Lasarte JJ, Ebert BL, Oriol A, Sureda A, Blanchard MJ, González-Montes Y, Bargay J, Lakhwani S, Ríos-Tamayo R, Rosiñol L, Martínez-López J, Lahuerta JJ, Bladé J, Mateos MV, San-Miguel J, Cedena MT, Puig N, Hagner PR, Ortiz Estevez M, Martínez-Climent JA, Paiva B.
MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.
BLOOD . : .
-
Guijarro-Martínez P, Sánchez-Cuervo M, Parro-Martín MÁ, Gómez Bayona E, Luna de Abia A, Chinea Rodríguez A, Herrera Puente P, Hinojo Marín B, Nova Ruiz G, López Jiménez J, Martín-Aragón S, Álvarez-Díaz AM.
Comprehensive PHARmaceutical care programme in patients undergoing ALLOgeneic haematopoietic stem cell transplantation (PHARALLO): protocol for a prospective interventional study with a historical control group.
European Journal of Hospital Pharmacy . : .
-
Hernández-Boluda JC, Arellano-Rodrigo E, Pérez-Encinas M, Raya JM, Gómez-Casares MT, Ferrer-Marín F, Hernández-Sánchez A, Fox ML, Angona A, Cuevas B, Mata-Vázquez MI, Ayala R, de Las Heras N, Mora E, García-Gutiérrez V, Senín A, Villarreal J, Xicoy B, Pérez-López R, García-Fortes M, González de Villambrosia S, Magro E, Ramírez MJ, Gómez P, Ramírez-Payer A, Martínez-Valverde C, Pérez-Lamas L, García-Hernández C, Gasior M, Juárez-Salcedo LM, Ibáñez F, Antelo ML, Guerrero L, Alvarez-Larrán A, Pereira A.
Survival outcomes and treatment patterns in myelofibrosis in the JAK inhibitor era.
BRITISH JOURNAL OF HAEMATOLOGY . : .
-
Carreño-Tarragona G, Gil-Manso R, Hernández-Boluda JC, Martínez-Ávila JC, Bellosillo B, Pérez-López R, Segura A, Ferrer-Marín F, Arellano-Rodrigo E, Angona A, García-Gutiérrez V, Noya MS, Blanco Á, Zamora L, Navarro M, Senín A, Magro E, Pastor-Galán I, Mata-Vázquez MI, Morales ML, Cuevas B, Vélez P, Mora E, Martínez-Bilbao C, Colmenares R, Alonso JM, Pérez-Encinas M, Caballero-Navarro G, Cortés MÁ, Santaliestra M, Raya JM, Blanco-Sánchez A, Hernández-Rivas JM, Martínez-López J, Ayala R, Álvarez-Larrán A.
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.
LEUKEMIA . : .
-
Jabbour E, Castagnetti F, Bardey-Kanaan M, Soichez R, Nguyen NT, Kelly D, Rizzo F, Patos P, García-Gutiérrez V.
Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
DRUG SAFETY . : .
-
Guerrero-Carreño X, Smits S, Esteban Lasso A, Samiotaki M, Calabuig-Navarro V, Iborra FJ, Rantanen F, Álvarez-Larrán A, Angona Figueras A, Bellosillo B, Sáez Marín AJ, García-Gutiérrez V, Dekkers DHW, Demmers JAA, Ferrer-Marín F, Hernández-Boluda JC, Matsakas A, Benavente Cuesta C, Vandenberghe P, Papadopoulos P.
Platelet Proteome Links Metabolism to Reactivity in Essential Thrombocythemia.
MOLECULAR & CELLULAR PROTEOMICS . 25(8): 101617-101617.
-
Pérez-Martínez A, Cabrero M, Montoro J, Sánchez-Escamilla M, Cuesta MÁ, de Soria VG, González-Sierra P, Humala K, López-Godino O, Luna de Abia A, López-Corral L, Sanz J, Pascual MJ, Piñana JL, Bermúdez A, Bellón JM, Filaferro S, Orti G, Balsalobre P, Solano C.
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).
BONE MARROW TRANSPLANTATION . : .